[1] ALEXEI DEGTEREV. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury[J]. Nature chemical biology, 2005, 1 2: 112-119. DOI:
10.1038/nchembio711[2] XIN TENG . Structure–activity relationship study of novel necroptosis inhibitors[J]. Bioorganic & Medicinal Chemistry Letters, 2005, 15 22: Pages 5039-5044. DOI:
10.1016/j.bmcl.2005.07.077[3] A DEGTEREV J Y J L Maki. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase[J]. Cell Death and Differentiation, 2012, 20 2: 366-366. DOI:
10.1038/cdd.2012.133[4] N TAKAHASHI. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models[J]. Cell Death & Disease, 2012, 3 11: e437-e437. DOI:
10.1038/cddis.2012.176[5] ALEXEI DEGTEREV. Addendum: Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury[J]. Nature chemical biology, 2013, 9 3: 192-192. DOI:
10.1038/nchembio0313-192a